Phenylalanine

coagulation factor II, thrombin ; Homo sapiens







47 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33137426 Repeat-dose animal toxicity studies and genotoxicity study with deactivated alkaline serine protease (DASP), a protein low in phenylalanine (PHE). 2020 Dec 2
2 19484400 Design, synthesis and biological evaluation of non-peptide PAR1 thrombin receptor antagonists based on small bifunctional templates: arginine and phenylalanine side chain groups are keys for receptor activity. 2010 Apr 1
3 19299505 Structure of granzyme C reveals an unusual mechanism of protease autoinhibition. 2009 Apr 7 1
4 19715676 Role of P2 glycine in determining the specificity of antithrombin reaction with coagulation proteases. 2009 Nov 6 2
5 17613990 Ultrastructural changes to rabbit fibrin and platelets due to aspartame. 2007 Mar-Apr 1
6 16839343 Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain. 2006 Jul 1
7 17074754 Rapid kinetics of Na+ binding to thrombin. 2006 Dec 29 1
8 16566136 [Interrelation between thrombin structure and its stability]. 2005 May-Jun 1
9 14978285 Crystal structure of the complex between thrombin and the central "E" region of fibrin. 2004 Mar 2 1
10 15137766 Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites. 2004 May 19 1
11 15189031 Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities. 2004 Jun 17 5
12 14531686 Probing the kinetic landscape of transient peptide-protein interactions by use of peptide (15)n NMR relaxation dispersion spectroscopy: binding of an antithrombin peptide to human prothrombin. 2003 Oct 15 3
13 11460501 Mutation of W215 compromises thrombin cleavage of fibrinogen, but not of PAR1 or protein C. 2001 1
14 10831587 Fluorescence properties and functional roles of tryptophan residues 60d, 96, 148, 207, and 215 of thrombin. 2000 Sep 22 1
15 10920258 Edge-to-face CH/pi interaction between ligand Phe-phenyl and receptor aromatic group in the thrombin receptor activation. 2000 Aug 1
16 11020444 Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. 2000 Nov 15 1
17 11087398 Role of residue Phe225 in the cofactor-mediated, allosteric regulation of the serine protease coagulation factor VIIa. 2000 Nov 28 1
18 10051558 Unexpected crucial role of residue 225 in serine proteases. 1999 Mar 2 1
19 9753458 Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen. 1998 Sep 29 3
20 9325262 Evidence for allosteric linkage between exosites 1 and 2 of thrombin. 1997 Oct 10 1
21 9398287 Ionic properties of membrane association by vitamin K-dependent proteins: the case for univalency. 1997 Dec 16 1
22 8615773 Thrombin stimulates wortmannin-inhibitable phosphoinositide 3-kinase and membrane blebbing in CHRF-288 cells. 1996 Mar 15 2
23 8745396 Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin. 1996 Feb 1
24 8855937 Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis. 1996 Oct 8 2
25 7563081 Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity. 1995 Oct 6 1
26 7582983 Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity. 1995 Aug 1
27 7721887 Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding. 1995 Apr 21 1
28 7739010 Characterization of a class of peptide boronates with neutral P1 side chains as highly selective inhibitors of thrombin. 1995 Apr 28 1
29 7802348 [Cellular receptor of thrombin]. 1994 1
30 7948726 Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations. 1994 Sep 1
31 8074680 Differential roles of two consecutive phenylalanine residues in thrombin receptor-tethered ligand peptides (SFFLRNP) in thrombin receptor activation. 1994 Aug 30 2
32 8381415 Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. 1993 Feb 5 2
33 8426361 Highly selective tripeptide thrombin inhibitors. 1993 Feb 5 1
34 1290488 Thrombin-specific inhibition by and slow cleavage of hirulog-1. 1992 May 1 1
35 1434539 Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration. 1992 Nov 2
36 1547237 Conformational stability of a thrombin-binding peptide derived from the hirudin C-terminus. 1992 Mar 10 1
37 1590777 Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin. 1992 May 1 1
38 2059196 Hirulog peptides with scissile bond replacements resistant to thrombin cleavage. 1991 Jun 28 1
39 2369894 Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin. 1990 Aug 1
40 2380171 The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. 1990 Aug 15 1
41 2480947 Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. 1989 Nov 1
42 2742826 High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen. 1989 Apr 4 2
43 2742827 High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen. 1989 Apr 4 1
44 2742828 High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen. 1989 Apr 4 1
45 3166991 High-resolution NMR studies of fibrinogen-like peptides in solution: resonance assignments and conformational analysis of residues 1-23 of the A alpha chain of human fibrinogen. 1988 Jun 14 1
46 3771562 Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273. 1986 Nov 15 2
47 7150549 Mechanism of action of thrombin on fibrinogen. Direct evidence for the involvement of phenylalanine at position P9. 1982 Nov 23 3